World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
112
Citations
41692
World Ranking
457
National Ranking
279

Medicine

D-Index
112
Citations
41786
World Ranking
5184
National Ranking
2803

Avindra Nath publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Avindra Nath sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 476 publications — 88th percentile

88% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Avindra Nath D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Avindra Nath sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 112 D-Index — 91st percentile

91% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Avindra Nath is affiliated with the National Institutes of Health in the United States. Their research contributions primarily focus on the field of Medicine, with extensive work in related subfields such as Neurology, Molecular Biology, Infectious Diseases, Virology, and Genetics.

The scientist's research covers multiple prominent topics within biomedical science, including:

  • Long-Term Effects of COVID-19
  • HIV Research and Treatment
  • Amyotrophic Lateral Sclerosis Research
  • Neurogenetic and Muscular Disorders Research
  • HIV-related health complications and treatments
  • COVID-19 Clinical Research Studies
  • Chromosomal and Genetic Variations

Avindra Nath's publication history includes high-impact articles such as:

  • Microvascular Injury in the Brains of Patients with Covid-19, 2020, published in New England Journal of Medicine
  • Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation, 2022, published in Cell
  • TDP-43 loss and ALS-risk SNPs drive mis-splicing and depletion of UNC13A, 2022, published in Nature
  • Nervous system consequences of COVID-19, 2022, published in Science
  • Progressive multifocal leukoencephalopathy and the spectrum of JC virus-related disease, 2020, published in Nature Reviews Neurology

The scientist has coauthored frequently with several researchers, notably:

  • Bryan Smith, with 35 joint publications
  • Joseph Steiner, with 19 joint publications
  • Gina Norato, with 18 joint publications
  • Tara T. Doucet-O'Hare, with 17 joint publications
  • Catherine DeMarino, with 17 joint publications

Avindra Nath's research is regularly published in venues including:

  • Neurology (19 publications)
  • Annals of Neurology (10 publications)
  • bioRxiv (Cold Spring Harbor Laboratory) (8 publications)
  • Neurotherapeutics (6 publications)
  • Neuro-Oncology (6 publications)

The scientist has also contributed to book publications, for instance:

  • Neuroinfectious Diseases - Case Report Collection 2022, published by Frontiers Media in 2023

Best Publications

  • Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma and Indolent B-Cell Malignancies Can Be Effectively Treated With Autologous T Cells Expressing an Anti-CD19 Chimeric Antigen Receptor

    James N. Kochenderfer;Mark E. Dudley;Sadik H. Kassim;Robert P.T. Somerville

  • Cancer regression and neurological toxicity following anti-MAGE-A3 TCR gene therapy.

    Richard A. Morgan;Nachimuthu Chinnasamy;Daniel Abate-Daga;Alena Gros

  • A full genome search in multiple sclerosis

    G C Ebers;K Kukay;D E Bulman;A D Sadovnick

  • TNF neutralization in MS - Results of a randomized, placebo-controlled multicenter study

    Arnason Bgw.;G Jacobs;M Hanlon;B H Clay

  • PML diagnostic criteria: Consensus statement from the AAN neuroinfectious disease section

    Joseph R. Berger;Allen J. Aksamit;David B. Clifford;Larry Davis

  • Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases

    David B Clifford;Andrea DeLuca;David M Simpson;Gabriele Arendt

  • Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia

    Katherine Conant;Alfredo Garzino-Demo;Avindra Nath;Justin C. McArthur

  • Microvascular Injury in the Brains of Patients with Covid-19.

    Myoung Hwa Lee;Daniel P. Perl;Govind Nair;Wenxue Li

  • Human endogenous retrovirus-K contributes to motor neuron disease

    Wenxue Li;Myoung Hwa Lee;Lisa Henderson;Richa Tyagi

  • Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain.

    Michael W. Ferenczy;Leslie J. Marshall;Christian D. S. Nelson;Walter J. Atwood

  • HIV-1 Protein Tat Induces Apoptosis of Hippocampal Neurons by a Mechanism Involving Caspase Activation, Calcium Overload, and Oxidative Stress

    Inna I. Kruman;Avindra Nath;Mark P. Mattson

  • Uptake of HIV-1 tat protein mediated by low-density lipoprotein receptor-related protein disrupts the neuronal metabolic balance of the receptor ligands.

    Ying Liu;Melina Jones;Cynthia M. Hingtgen;Guojun Bu

  • Transient Exposure to HIV-1 Tat Protein Results in Cytokine Production in Macrophages and Astrocytes A HIT AND RUN PHENOMENON

    Avindra Nath;Katherine Conant;Peiqin Chen;Catherine Scott

  • Identification of active loci of a human endogenous retrovirus in neurons of patients with amyotrophic lateral sclerosis

    Renée Douville;Jiankai Liu;Jiankai Liu;Jeffrey Rothstein;Avindra Nath

  • PML-IRIS in patients with HIV infection Clinical manifestations and treatment with steroids

    K. Tan;R. Roda;L. Ostrow;J. McArthur

  • Identification of a human immunodeficiency virus type 1 Tat epitope that is neuroexcitatory and neurotoxic.

    Avindra Nath;Karen Psooy;Carol Martin;Bodo Knudsen

  • HIV-1 Tat induces monocyte chemoattractant protein-1-mediated monocyte transmigration across a model of the human blood-brain barrier and up-regulates CCR5 expression on human monocytes.

    Jonathan M. Weiss;Avindra Nath;Eugene O. Major;Joan W. Berman

  • Immediate anticoagulation of embolic stroke: brain hemorrhage and management options

    Robert G. Hart;Kathleen I. Lock-Wood;Antoine M. Hakim;Richard Koller

  • Cell death in HIV dementia.

    M P Mattson;M P Mattson;N J Haughey;A Nath

  • Progressive multifocal leukoencephalopathy and the spectrum of JC virus-related disease.

    Irene Cortese;Daniel S Reich;Avindra Nath

  • Pembrolizumab Treatment for Progressive Multifocal Leukoencephalopathy

    Irene Cortese;Pawel Muranski;Yoshimi Enose-Akahata;Seung-Kwon Ha

  • Human immunodeficiency virus type 1 tat activates non-N-methyl-D-aspartate excitatory amino acid receptors and causes neurotoxicity.

    David S. K. Magnuson;Bodo E. Knudsen;Jonathan D. Geiger;Robert M. Brownstone

  • Neurobiological aspects of human immunodeficiency virus infection: neurotoxic mechanisms.

    Avindra Nath;Jonathan Geiger

  • The Tat Protein of HIV-1 Induces Tumor Necrosis Factor-α Production IMPLICATIONS FOR HIV-1-ASSOCIATED NEUROLOGICAL DISEASES

    Peiqin Chen;Michael Mayne;Christopher Power;Avindra Nath

Frequent Co-Authors

Justin C. McArthur
Justin C. McArthur Johns Hopkins University School of Medicine
Norman J. Haughey
Norman J. Haughey Tulane University
Eugene O. Major
Eugene O. Major National Institutes of Health
Joseph R. Berger
Joseph R. Berger University of Pennsylvania
Christopher Power
Christopher Power University of Alberta
Mark P. Mattson
Mark P. Mattson Johns Hopkins University
Robert J. Cotter
Robert J. Cotter Johns Hopkins University School of Medicine
Peter A. Calabresi
Peter A. Calabresi Johns Hopkins University School of Medicine
David B. Clifford
David B. Clifford Washington University in St. Louis
Jonathan D. Geiger
Jonathan D. Geiger University of Manitoba

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can open doors to diverse career opportunities. Many students find accelerated nursing programs appealing as they offer a quick path to becoming a nurse practitioner. Programs like these are highlighted in accelerated nurse practitioner programs, which combine rigorous training with the flexibility of online learning.

If you’re switching fields or starting fresh, there are also options specifically designed for those without prior medical experience. The 12-month accelerated nursing programs online for non nurses are crafted to fast-track non-nurses into nursing roles, providing comprehensive education in a condensed timeline.

Ease of admission can be a significant factor when choosing a program. For aspiring nurses, it’s worth reviewing the easiest accelerated nursing programs to get into, which focus on streamlined application processes without compromising quality.

Similarly, those aiming for foundational licensed practical nurse roles can find valuable information on which lpn programs are easiest to get into. This insight helps students make informed decisions based on program accessibility and career goals.

Best Scientists Citing Avindra Nath

Trending Scientists

Recently Published Articles